Stevanato Group S.p.A (STVN) Other Non-Current Assets (2020 - 2026)
Stevanato Group S.p.A (STVN) posted quarterly Other Non-Current Assets of $7.5 million for Q1 2026, down 49.76% year-over-year from $14.9 million in Q1 2025, and up 10.91% quarter-over-quarter from $6.8 million in Q4 2025.
Stevanato Group S.p.A (STVN) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Stevanato Group S.p.A (STVN) has reported Other Non-Current Assets for 7 consecutive years, with $7.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 49.76% year-over-year to $7.5 million; the TTM figure through Mar 2026 stood at $7.5 million (down 49.76% YoY), while the FY2025 annual figure was $6.8 million, up 17.2% from the prior year.
- Other Non-Current Assets advanced to $7.5 million in Q1 2026 per STVN's latest filing, from $6.8 million in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $15.6 million in Q3 2025 and bottomed at $920554.5 in Q3 2022.
- Historically, Other Non-Current Assets has averaged $6.4 million across 5 years, with a median of $6.0 million in 2024.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets sank 84.39% — and 2023, when it jumped 559.26%.
- Stevanato Group S.p.A's Other Non-Current Assets stood at $1.0 million in 2022, then jumped by 374.56% to $4.8 million in 2023, then advanced by 19.18% to $5.8 million in 2024, then advanced by 17.2% to $6.8 million in 2025, then increased by 10.91% to $7.5 million in 2026.
- Business Quant data shows STVN's Other Non-Current Assets at $7.5 million in Q1 2026, $6.8 million in Q4 2025, and $15.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | - |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 2.55 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 434.00 Mn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 457.39 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 22.91 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | 82.80 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 904.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 672.80 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 669.00 Mn |
| 10 | Stevanato Group S.p.A | 6.18 Bn | 6.07 Bn | 100.91 Mn | 3.17 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.17 Mn |
| Mar 31, 2026 | 7.50 Mn |
| Dec 31, 2025 | 6.76 Mn |
| Sep 30, 2025 | 15.60 Mn |
| Jun 30, 2025 | 15.19 Mn |
| Mar 31, 2025 | 14.93 Mn |
| Dec 31, 2024 | 5.77 Mn |
| Sep 30, 2024 | 6.04 Mn |
| Jun 30, 2024 | 6.07 Mn |
| Mar 31, 2024 | 5.08 Mn |
| Dec 31, 2023 | 4.84 Mn |
| Sep 30, 2023 | 6.07 Mn |
| Jun 30, 2023 | 6.16 Mn |
| Mar 31, 2023 | 4.00 Mn |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 920,554.46 |
| Jun 30, 2022 | 961,418.08 |
| Mar 31, 2022 | 1.50 Mn |
| Dec 31, 2021 | 1.49 Mn |
| Sep 30, 2021 | 5.90 Mn |